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Abstract
Background: The application of 22-MHz high-frequency ultrasound allows for visualization of the inner part of the sural
nerve. The aim of this study was to evaluate the morphological changes of sural nerves in patients with type 2 diabetes
mellitus using ultrasound.
Materials and Methods: The thickness/width (T/W) ratio, the cross-sectional area (CSA) of the sural nerves and the
maximum thickness (MT) of the nerve fascicles were measured in 100 patients with type 2 diabetes mellitus and 50 healthy
volunteers using 22-MHz ultrasound. Receiver operating characteristic (ROC) curves were plotted to determine the optimal
cut-off values as well as the sensitivities and specificities. All parameters were significantly different between the subject and
control groups. The ROC curves demonstrated that the MT was the most predictive of diabetic cutaneous neuropathy, with
an optimal cut-off value of 0.365 mm that yielded a sensitivity of 90.3% and a specificity of 87.7%.
Conclusions: The results of this study suggest that 22-MHz ultrasound may be a valuable tool for evaluating diabetic
cutaneous nerve neuropathy.
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Introduction
The most prevalent type of diabetic peripheral neuropathy
(DPN) is distal symmetric, peripheral polyneuropathy, which is
primarily sensory in nature [1]. The initial effect of the
degenerative process is thought to occur in the cutaneous nerve
fiber endings [2]. The diagnosis of diabetic cutaneous neuropathy
is based primarily on clinical examination and nerve conduction
studies (NCS). However, studies focusing on monitoring the
morphological changes of diabetic cutaneous nerves by ultrasound
(US) have not been previously performed. The newer 22-MHz
high-frequency US allows for visualization of the inner part of the
sural nerve (SN). The aim of this study was to evaluate the
morphological changes of SNs in patients with type 2 diabetes
mellitus using 22-MHz high-frequency US.
Materials and Methods
The study was approved by the ethics committee of the
Shanghai Jiaotong University Affiliated Sixth People’s Hospital,
and written consent was obtained from all participants.
This was a prospective study, consisting of subjects consisted of
100 consecutive patients with type 2 diabetes and 50 healthy
volunteers as controls. The diabetic patients were divided into a
neuropathic group and a non-neuropathic group. Diabetic
neuropathy was diagnosed if one or two of the following criteria
were present: 1) the Diabetic Neuropathy Symptom (DNS) score
was 1 or higher, which was considered positive [3] and 2) routine
motor and sensory NCS had been performed, as suggested
previously by Fioretti and Ziegler [4,5]. The control group
consisted of 50 healthy volunteers who did not have neuropathic
symptoms or any risk factors for neuropathy based on a
neurological examination.
Sonographic examinations were performed with 22-MHz
linear-array transducers connected to a MyLabSat (Esaote
Biomedica, Genoa, Italy). The sonographer was blinded to the
NCS results. All of the subjects were in the prone position during
the exam. The transducer was placed in a transverse position on
the lower section of the calf. To make sure the sural nerve was not
compressed, the operator exerted minimal pressure on the skin
and any compression that could cause deformation of the lesser
saphenous vein was avoided. On the transverse sonograms, the SN
usually appeared as an ovoid hypoechoic reticular structure with a
hyperechoic rim near the lesser saphenous vein (Fig. 1a). On the
longitudinal sonograms, the SN appeared as multiple hypoechoic
bands corresponded to neuronal fascicles, which were separated
by hyperechoic lines that correspond to the epineurium (Fig. 1b).
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e32730The thickness divided by width on the transverse image of the
SN was defined as the thickness/width (T/W) ratio, which is an
indicator of the level of swelling and deformation of the SN (Fig. 2).
The cross-sectional areas (CSAs) of the SN, which were traced
along the outer hyperechoic rim on the transverse sonograms,
were calculated using the formula for an ellipse after determina-
tion of six optional points along the nerve (Fig. 2). The maximum
thickness (MT) of the nerve fascicles was measured along the short
axes (Fig. 2). However, there are some anatomical variants of the
SN [6,7]. The classic pattern of sural nerve formation is the union
of the medial sural cutaneous nerve (MSCN) and the lateral sural
cutaneous nerve (LSCN). The union of the MSCN and LSCN
occurred most frequently in the distal third of the leg [8].
Therefore, we chose a location approximately 5 cm proximal to
the lateral malleolus as the measurement site. Each SN was
measured three times, and the mean value was used in further
calculations. Intra-observer reliability was evaluated in 30 cases
that were selected by another radiologist.
The results of the statistical analysis are presented as the
mean6SD, and a P-value of less than 0.05 was considered
statistically significant. The one-way ANOVA was used to
compare the groups. The intra-observer reliability was tested with
the intra-class correlation coefficient (ICC). Receiver operating
characteristic (ROC) curves were employed to determine the
optimal cut-off values for useful ultrasonographic variables.
Results
A total of 92 SNs from the neuropathic group (21 males and 25
females; mean age, 65.1610.2 years; BMI, 24.364.7), 108 SNs
from the non-neuropathic group (28 males and 26 females; mean
age, 63.269.8 years; BMI, 23.563.9), and 100 SNs from the
control group (25 males and 25 females; mean age,
62.5613.7 years; BMI, 24.762.8) were examined using US.
There were no statistically significant differences in age or BMI
between the groups; however, there was a statistically significant
difference in the duration of diabetes between the neuropathic
group (7.562.6 years) and the non-neuropathic group
(3.961.8 years).
The inner part of the SN, consisting of the fascicle, perineurium
and epineurium, was identified in all participants. The ICCs for
the CSA, T/W ratio and MT were 0.810, 0.879 and 0.912,
respectively (p,0.001). The types of SN were shown in
Table 1.The mean values and standard deviations (SD) of these
parameters along with the statistical significance of the differences
between the control group, the non-neuropathic group and the
neuropathic group are listed in Table 2. There was a statistically
significant difference between the three groups regarding all US
parameters investigated.
The ROC (Fig.3) curve of the MT revealed that the area under
the curve (AUC) was 0.918 (p,0.001) with an optimal cut-off
value of 0.365 mm, yielding a sensitivity of 90.3% and a specificity
of 87.7%. For the CSA, the ROC curve demonstrated that the
AUC was 0.755 (p,0.001) with an optimal cut-off value of
1.685 mm
2, resulting in a 64.5% sensitivity and an 82.2%
specificity. Furthermore, the ROC curve of the T/W ratio
Figure 1. Transverse and longitudinal sonograms of the SN. a)
Transverse sonogram of the SN. A transverse sonogram showing the SN
(arrows) near the lesser saphenous vein (V) SN appeared as an ovoid
hypoechoic reticular structure with a hyperechoic rim. b) Longitudinal
sonogram of the SN. A Longitudinal sonogram of the SN showing the
perineurium (dashed arrows) and epineurium (solid arrow).
doi:10.1371/journal.pone.0032730.g001
Figure 2. Image analysis on T/W ratio, CSA and MT of the SN. a) Transverse sonogram of the SN. b) Schematic diagram associated with the
measurements.
doi:10.1371/journal.pone.0032730.g002
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value of 0.528, yielding a 71% sensitivity and a 68.8% specificity.
The MT of SN had the best diagnostic accuracy.
Discussion
DPN is an important chronic complication of diabetes.
Worsening neuropathy is accompanied by a increasing loss of
sensory nerve fibers. When the fibers undergo degeneration or
impaired remyelination, they release impulses of positive symp-
toms. With progression of the disease, the negative symptoms of
sensory loss increased [9]. Clinical examination and NCS are used
to support the diagnosis of diabetic cutaneous neuropathy. A
growing number of researchers now believe that it is important to
identify subclinical neuropathy before the clinical findings appear
because patients may respond better to treatment if the condition
is diagnosed early [10]. However, NCS also has limitations and
disadvantages. Its application is painful and it cannot assess the
sural nerve anatomy. Therefore, there continues to be controversy
about the sensitivity and specificity of NCS for the diagnosis of
subclinical neuropathy [1].
This study demonstrates that 22-MHz high-frequency US is a
painless diagnostic technique that can be used to evaluate
morphological changes in the SNs of diabetic patients. Because
the inner parts of the SN could be clearly identified, the
morphological parameters could be accurately measured.
The SN is commonly used to study distal sensory polyneurop-
athy in diabetic patients. However, there are some anatomical
variants of the SN. We classified the SN into three types using US
[11]. Type I was the classic pattern of sural nerve formation, in
which both the MSCN and the LSCN contributed to the
formation of the SN. Type II lacked the LSCN, whereas type
III lacked the MSCN. In this study, type I was more common
(85%) than the other types. Furthermore, in type I, the union of
the MSCN and LSCN occurred most frequently in the distal third
of the leg [8]. For this reason, we choose a measurement site that
was 5 cm proximal to the lateral malleolus as the measurement
site.
Conventional high-frequency ultrasound with 10–14 MHz can
also be used to identify the SN [11–15], but it does not reveal the
investigator to evaluate the fine structure of the inner SN. Several
reports have focused on the use of ultrasound to evaluate nerve
decompression in diabetic patients [16,17]. Studies focusing on
monitoring the morphological changes of the cutaneous nerves of
diabetics by US have not been previously performed.
The pathology of diabetic neuropathy is characterized by the
progressive loss of myelinated nerve fiber. The nerve swelling is
thought to be the result of a cascade of the following events:
thickening of the vasculature, association of the basement
membranes with perineurial and Schwann cells; accumulation of
microfibrillar material in the vicinity of perineurial cells; and an
increased diameter of endoneurial collagen fibrils [9,18].We found
that the MT was the most predictive parameter for diabetic
cutaneous neuropathy, with a threshold values of 0.365, yielding a
sensitivity of 90.3% and a specificity of 87.7%. Therefore, the MT
may be considered an indicator for the level of swelling of the
nerve fascicles. In the present study, CSA maybe the most
commonly used for evaluation of nerve swelling among the US
criterion for the evaluation of nerve swelling. Our study also
demonstrated that CSA might be an important indicator for
monitoring the morphological changes of diabetic cutaneous
nerves. The optimal cut-off value for the CSA was 1.685 mm
2,
yielding an 82.2% specificity, and a relatively low sensitivity
(64.5%). However, our CSA value in the control group was much
lower than previous report (5.361.8 mm
2) for 15 MHz US [19].
The possible explanation for this discrepancy is the 15 MHz probe
used in the previous study, which may have made the observation
and measurement of nerve borders difficult. In the study by Ding J
[20], a quantitative analysis to determine the CSA of the SN in
healthy Chinese subjects was performed by morphometric analysis
during biopsy. The authors found that the CSA of the SN ranged
from 0.60 mm
2–1.23 mm
2, which was similar to our measure-
ments. Otherwise, the T/W ratio, which was used to detect the
level of of SN deformation, was also used to evaluate the
morphological changes in our study. This index was similar to the
‘‘flattening ratio’’, which was initially emphasized by Buchberger
Table 1. Ultrasound-detected anatomical types of SNs.
Type of SN Control group Non-neuropathic group Neuropathic group Total
n% n % n % n%
I 8 5 8 5 9 48 77 6 8 3 2 5 5 8 5
II 14 14 13 12 15 16 42 14
III 1 1 1 1 1 1 3 1
Total 100 100 108 100 92 100 300 100
doi:10.1371/journal.pone.0032730.t001
Table 2. Comparison and statistical significance of the ultrasonographic parameters.
Control group Non-neuropathic group Neuropathic group p
CSA(mm
2) 1.4460.34 1.5260.35 1.8860.50 0.024
MT(mm) 0.3360.04 0.3660.08 0.4560.07 ,.001
T/W ratio 0.5160.07 0.5660.10 0.5960.09 0.002
Abbreviations: CSA, cross-sectional area; MT, the maximum thickness of the neuronal fascicles; T/W ratio, thickness/width ratio. All values in the three groups are the
mean6standard deviation.
doi:10.1371/journal.pone.0032730.t002
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the neuropathic group (0.5960.09) compared to patients in the
non-neuropathic group (0.5660.10) and the control group
(0.5160.07). Moreover, assessment of the T/W ratio and the
MT was first proposed as a means of examining nerve injuries.
However, additional clinical studies with large sample sizes are
required to establish the usefulness of these parameters.
The results of this study suggest that US may be a valuable tool
for evaluating diabetic cutaneous nerve neuropathy. However, we
believe that our study is only a preliminary report. The main
limitation of our study is that we did not compare our sonographic
findings to changes in histological appearance. Further studies are
needed to overcome these limitations.
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